Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema

Final draft guidance

Final draft guidance (PDF 143 KB)

Committee papers (PDF 5.05 MB)

Public committee slides (PDF 386 KB)

Equality impact assessment (PDF Version) (PDF 173 KB)

Final scope (PDF 180 KB)

Final stakeholder list (PDF 167 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 353 KB)

Equality impact assessment (Scoping) (PDF 130 KB)

Draft scope pre referral (PDF 194 KB)

Draft matrix pre referral (PDF 170 KB)